Treatment of parasitic infestation in children with malignant neoplasms.
D001196:Ascariasis / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D004802:Eosinophilia / Q000150:complications; D005260:Female; D005664:Furazolidone / Q000008:administration & dosage; D005873:Giardiasis / Q000188:drug therapy; D006801:Humans; D007223:Infant; D007680:Kidney Neoplasms / Q000150:complications; D007945:Leukemia, Lymphoid / Q000150:complications; D008228:Lymphoma, Non-Hodgkin / Q000150:complications; D008297:Male; D009369:Neoplasms / Q000150:complications*; D010123:Oxyuriasis / Q000188:drug therapy; D010272:Parasitic Diseases / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D010879:Piperazines / Q000008:administration & dosage; D011774:Pyrvinium Compounds / Q000008:administration & dosage; D013322:Strongyloidiasis / Q000188:drug therapy; D013827:Thiabendazole / Q000008:administration & dosage; D014257:Trichuriasis / Q000188:drug therapy; D009396:Wilms Tumor / Q000150:complications
D010879:Piperazines; D011774:Pyrvinium Compounds; D005664:Furazolidone; D013827:Thiabendazole